Non-Small Cell Lung Cancer May Confer Highest Risk for COVID-19
The researchers noted that medical distancing for those with cancer could help prevent the spread of the virus in this highly vulnerable population.
Lung Cancer
FDA-Approved Non-Small Cell Lung Cancer (NSCLC) Treatments
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
Novel Bispecific Antibody Gets Breakthrough Therapy Status for NSCLC
The FDA has granted Breakthrough Therapy designation to JNJ-6372 for the treatment of patients with NSCLC with EGFR Exon 20 insertion mutations.
Clinicians Should Consider EVALI in Patients With a History of Vaping
Despite California’s legal cannabis market, 75% of products that contained THC were obtained from informal sources.
Brigatinib Receives Priority Review for First-Line Treatment of ALK+ Metastatic NSCLC
The Food and Drug Administration has granted Priority Review for the supplemental New Drug Application (sNDA) for brigatinib (Takeda) as a first-line treatment for patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC).
Atezolizumab Monotherapy Under Review for First-Line Advanced NSCLC Treatment
The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for atezolizumab (Tecentriq®; Genentech) as a first-line monotherapy in patients with advanced non-squamous and squamous non-small cell lung cancer (NSCLC) without EGFR or ALK mutations with high PD-L1 expression (TC3/IC3 wild-type [WT]), as determined by PD-L1 biomarker testing.
Lurbinectedin Under Review for Relapsed Small Cell Lung Cancer
The FDA has accepted for Priority Review the NDA for lurbinectedin for the treatment of patients with small cell lung cancer who have progressed after prior platinum-containing therapy.
Lung Cancer Mortality in Former Smokers Reduced With Low-Dose CT Screening
Volume-based, low-dose computed tomographic screening at various intervals may reduce the risk of lung cancer mortality in people who were current smokers or had a history of smoking.
Patient Decision Aid Informs Patients on Lung Cancer Screening
Tobacco quit lines are an effective way to disseminate patient decision aids.
Lung Cancer Incidence Rates Trending Higher in Young Women vs Men
Age-specific lung cancer incidence rates generally decreased in all countries in men, while rates varied across countries in women.
Next post in Lung Cancer
